Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-05-22 to 2024-06-13
Current total value of award: $25683.45
Description: 4564750945!XOLAIR 300 MG/2 ML SYRINGE 2ML